Monday, December 1, 2008 - 8:56PM EST

Review Articles

41. Cervical cancer: radiotherapy and hyperthermia.

Author
van der Zee J; van Rhoon GC;
Institution
Department of Radiation Oncology, Hyperthermia Unit, Rotterdam, The Netherlands. j.vanderzee@erasmusmc.nl
Journal
Int J Hyperthermia. 2006 May;22(3):229-34.
Abstract URL
Click here to view abstract

42. Long-term risk of invasive cervical cancer after treatment of squamous cervical intraepithelial neoplasia.

Author
Soutter WP; Sasieni P; Panoskaltsis T;
Institution
Imperial College, Hammersmith Hospital Campus, London, United Kingdom. p.soutter@imperial.ac.uk
Journal
Int J Cancer. 2006 Apr 15;118(8):2048-55.
Abstract URL
Click here to view abstract

43. Risk of second cancers after radiotherapy for cervical cancer.

Author
Ohno T; Kakinuma S; Kato S; Tsujii H; Shimada Y;
Institution
Research Center for Charged Particle Therapy, National Institute of Radiological Sciences, 4-9-1 Anagawa, Chiba, Japan. t_ohno@nirs.go.jp
Journal
Expert Rev Anticancer Ther. 2006 Jan;6(1):49-57.
Abstract URL
Click here to view abstract

44. Chemoprevention of cervical cancer.

Author
Sasieni P;
Institution
Cancer Research UK Centre for Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK. peter.sasieni@cancer.org.uk
Journal
Best Pract Res Clin Obstet Gynaecol. 2006 Apr;20(2):295-305. Epub 2006 Jan 4.
Abstract URL
Click here to view abstract

45. Vaccines for cervical cancer.

Author
Lowndes CM;
Institution
Journal
Epidemiol Infect. 2006 Feb;134(1):1-12.

46. Cervical cancer screening in older women.

Author
Dallred C;
Institution
Department of Nursing Professional Development and Education, University of Texas M.D. Anderson Cancer Center, Houston, USA. csdallre@mdanderson.org
Journal
Clin J Oncol Nurs. 2006 Feb;10(1):31-3.

47. A systematic review of postcoital bleeding and risk of cervical cancer.

Author
Shapley M; Jordan J; Croft PR;
Institution
Primary Care Sciences Research Centre, Keele University, Staffordshire. m.shapley@cphc.keele.ac.uk
Journal
Br J Gen Pract. 2006 Jun;56(527):453-60.
Abstract URL
Click here to view abstract

48. Effects of different chemotherapy regimens on survival for advanced cervical cancer: systematic review and meta-analysis.

Author
Tzioras S; Pavlidis N; Paraskevaidis E; Ioannidis JP;
Institution
Department of Obstetrics and Gynaecology, University of Ioannina School of Medicine, Ioannina, Greece.
Journal
Cancer Treat Rev. 2007 Feb;33(1):24-38. Epub 2006 Nov 16.
Abstract URL
Click here to view abstract

49. Overview of cervical cancer in the developing world. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer.

Author
Sankaranarayanan R;
Institution
Head, Screening Group, World Health Organization - International Agency for Research on Cancer, Lyon 69008, France. sankar@iarc.fr
Journal
Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S205-10.

50. HPV DNA testing for cervical cancer screening. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer.

Author
Wright TC Jr;
Institution
Department of Pathology, Columbia University, New York, USA. tcw1columbia.edu
Journal
Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S239-46.
Pages: 1 2 3 4 5 6